200 related articles for article (PubMed ID: 33000319)
1. Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?
Elsayed M; Cheng B; Xing M; Sethi I; Brandon D; Schuster DM; Bercu Z; Galt J; Barron B; Kokabi N
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):254-260. PubMed ID: 33000319
[TBL] [Abstract][Full Text] [Related]
2. Lung shunt fraction calculations before Y-90 transarterial radioembolization: Comparison of accuracy and clinical significance of planar scintigraphy and SPECT/CT.
Young S; Flanagan S; D'Souza D; Todatry S; Ragulojan R; Sanghvi T; Golzarian J
Diagn Interv Imaging; 2023 Apr; 104(4):185-191. PubMed ID: 36604211
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic
Struycken L; Patel M; Kuo P; Hennemeyer C; Woodhead G; McGregor H
AJR Am J Roentgenol; 2022 Apr; 218(4):728-737. PubMed ID: 34704460
[No Abstract] [Full Text] [Related]
4. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
5. Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
Kallini JR; Gabr A; Hickey R; Kulik L; Desai K; Yang Y; Gates VL; Riaz A; Salem R; Lewandowski RJ
Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1213-1222. PubMed ID: 28280976
[TBL] [Abstract][Full Text] [Related]
6. Factors modulating
Lopez BP; Mahvash A; Long JP; Lam MGEH; Kappadath SC
J Appl Clin Med Phys; 2022 Dec; 23(12):e13734. PubMed ID: 35906892
[TBL] [Abstract][Full Text] [Related]
7. Calculation of lung mean dose and quantification of error for
Lopez B; Mahvash A; Lam MGEH; Kappadath SC
Med Phys; 2019 Sep; 46(9):3929-3940. PubMed ID: 31063600
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
Gaba RC; Zivin SP; Dikopf MS; Parvinian A; Casadaban LC; Lu Y; Bui JT
Radiology; 2014 May; 271(2):602-12. PubMed ID: 24533871
[TBL] [Abstract][Full Text] [Related]
9. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization.
Olorunsola OG; Kohi MP; Behr SC; Kolli PK; Taylor AG; Tong RT; LaBerge JM; Kerlan RK; Fidelman N
J Vasc Interv Radiol; 2015 Oct; 26(10):1472-8. PubMed ID: 26296737
[TBL] [Abstract][Full Text] [Related]
10. 90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival.
Xing M; Lahti S; Kokabi N; Schuster DM; Camacho JC; Kim HS
Clin Nucl Med; 2016 Jan; 41(1):21-7. PubMed ID: 26222534
[TBL] [Abstract][Full Text] [Related]
11. SPECT and CT misregistration reduction in [
Lu Z; Chen G; Jiang H; Sun J; Lin KH; Mok GSP
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2319-2330. PubMed ID: 36877236
[TBL] [Abstract][Full Text] [Related]
12. Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer.
Yu N; Srinivas SM; Difilippo FP; Shrikanthan S; Levitin A; McLennan G; Spain J; Xia P; Wilkinson A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):834-9. PubMed ID: 22871239
[TBL] [Abstract][Full Text] [Related]
13. The value of
Allred JD; Niedbala J; Mikell JK; Owen D; Frey KA; Dewaraja YK
EJNMMI Res; 2018 Jun; 8(1):50. PubMed ID: 29904808
[TBL] [Abstract][Full Text] [Related]
14. Measurement of the Tumor-to-Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-Dimensional Perfusion Angiography, Technetium-99m Macroaggregated Albumin, and Yttrium-90 SPECT/CT.
Brunson CP; McGregor HJ; Hennemeyer CT; Patel MV; Woodhead GJ; Young SJ
J Vasc Interv Radiol; 2024 Jan; 35(1):94-101. PubMed ID: 37783268
[TBL] [Abstract][Full Text] [Related]
15. Radioembolization lung shunt estimation based on a
Kunnen B; van der Velden S; Bastiaannet R; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2018 Oct; 45(10):4744-4753. PubMed ID: 30179259
[TBL] [Abstract][Full Text] [Related]
16. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
[TBL] [Abstract][Full Text] [Related]
17. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of different CT maps for attenuation correction and segmentation in static
Lu Z; Chen G; Lin KH; Wu TH; Mok GSP
Med Phys; 2021 Jul; 48(7):3842-3851. PubMed ID: 34013551
[TBL] [Abstract][Full Text] [Related]
19. Repeat Evaluation of Lung Shunt Fraction is Unnecessary: A Retrospective Observational Study of Successive Lung Shunt Fractions from Variable Arterial Distributions in Patients Undergoing Radioembolization of Primary and Secondary Liver Tumors.
Bulman JC; Zurkiya O; Wu V; Wehrenberg-Klee E; Palmer E; Chow D; Brook A; Ganguli S
J Vasc Interv Radiol; 2021 Mar; 32(3):412-418. PubMed ID: 33341340
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Study of Quantitative SPECT/CT for Evaluation of Lung Shunt Fraction Before SIRT of Liver Tumors.
Dittmann H; Kopp D; Kupferschlaeger J; Feil D; Groezinger G; Syha R; Weissinger M; la Fougère C
J Nucl Med; 2018 Sep; 59(9):1366-1372. PubMed ID: 29371406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
